PDF
ContextVision AB: Threshold exceeded for major shareholding notification due to repurchases of own shares
2026-10-21 08:48:06
Stockholm 21 October 2026 -- ContextVision AB (publ) ("ContextVision" or the
"Company") hereby announces, in accordance with Chapter 4, Section 18 of the
Swedish Financial Instruments Trading Act (1991:980), that on 19 October 2026
ContextVision acquired 15,086 own shares. ContextVision's total holding of own
shares thereafter amounted to 3,872,246 shares, which means that the Company's
holding of own shares amounted to 5.01 percent of the total number of shares
and that the holding had therefore exceeded the threshold of 5 percent of the
total number of shares in ContextVision.
The total number of shares in ContextVision amounts to 77,367,500 shares.
The repurchases form part of the share buy-back programme that ContextVision
announced on 9 September 2026. Buy-backs may be made on one or several
occasions from 10 September 2026 up to and including 29 January 2027. The
maximum total amount for which shares may be repurchased may not exceed NOK
12,000,000, and the maximum number of shares that may be repurchased may not
exceed 2,000,000 shares. DNB Carnegie is carrying out the buy-back programme
under a mandate from ContextVision.
This is information that ContextVision is obliged to make public pursuant to
the EU Market Abuse Regulation and that is subject to the disclosure
requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.
This stock exchange announcement was published by Richard Hallström, CFO, on
the time and date provided.
For further information, please contact:
Richard Hallström, CFO
Email: richard.hallstrom@contextvision.com
About ContextVision AB:
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound,
X-ray and MRI equipment around the world. Our expertise is to develop powerful
software products, based on proprietary technology and artificial intelligence
for image-based applications. Our cutting-edge technology helps clinicians
accurately interpret medical images, a crucial foundation for better diagnosis
and treatment. The company, established in 1983, is based in Sweden with local
representation in the U.S., Japan, China and Korea. ContextVision is listed on
the Oslo Stock Exchange under the ticker CONTX.
This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-10-21 08:48 CEST.
agency of the contact persons set out above\, at 2026-10-21 08:48 CEST.\